Serum 25(OH)D and diabetes risk in adults with prediabetes: evidence, potential mechanisms, and implications
The Journal of Clinical Endocrinology & Metabolism · 12.11.2026
DOI: 10.1210/clinem/dgag460 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 12.11.2026. Verfasst von Bess Dawson-Hughes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston MA 02111.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Correcting vitamin D deficiency to reach 25-hydroxyvitamin D levels in the replete range (≥ 20 ng/mL, as defined by the National Academy of Medicine) improves insulin secretion and sensitivity. Emerging evidence indicates that vitamin D may have a more extensive role in reducing risk of type 2 diabetes in selected adults with prediabetes. Specifically, vitamin D supplementation at doses sufficient to achieve 25-hydroxyvitamin D levels ≥ 40 ng/ml appears to confer additional benefit in reducing diabetes risk in subsets of the population with prediabetes. Herein we review evidence that achieving relatively high 25-hydroxyvitamin D levels may lower risk of progression to type 2 diabetes in selected vitamin D-replete adults with prediabetes. We consider potential mechanisms by which this may occur. We also discuss the potential benefits and risks of high-dose vitamin D supplementation across subgroups defined by genetic profile, age, and the presence of additional comorbidities. These findings indicate a potential role for a precision nutrition approach with high-dose vitamin D supplementation to lower risk of type 2 diabetes in adults with prediabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston MA 02111.
- Kaiser Permanente Center for Health Research, Portland.
- Division of Endocrinology, Tufts Medical Center, Boston MA 02111.
ORCID-Profile: Bess Dawson-Hughes
Zitieren
APA
Dawson-Hughes, B., LeBlanc, E., & Pittas, A. G. (2026). Serum 25(OH)D and diabetes risk in adults with prediabetes: evidence, potential mechanisms, and implications. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag460
Vancouver
Dawson-Hughes B, LeBlanc E, Pittas AG. Serum 25(OH)D and diabetes risk in adults with prediabetes: evidence, potential mechanisms, and implications. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag460
BibTeX
@article{DawsonHughes2026,
author = {Dawson-Hughes, Bess and LeBlanc, Erin and Pittas, Anastassios G},
title = {Serum 25(OH)D and diabetes risk in adults with prediabetes: evidence, potential mechanisms, and implications},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag460}
}
EUVIMED